Trial Profile
Association Between Socioeconomic Factors and Use of Direct Oral Anticoagulants Versus Standard of Care (Warfarin) in Patients With Non-valvular Atrial Fibrillation in Sweden
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Oct 2018
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Rivaroxaban (Primary) ; Warfarin
- Indications Stroke
- Focus Therapeutic Use
- Sponsors Bayer
- 04 Oct 2018 New trial record